These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32515660)

  • 41. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vegetarian Dietary Patterns and Cardiovascular Disease.
    Kahleova H; Levin S; Barnard ND
    Prog Cardiovasc Dis; 2018; 61(1):54-61. PubMed ID: 29800598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Consumption of energy-dense diets in relation to cardiometabolic abnormalities among Iranian women.
    Esmaillzadeh A; Boroujeni HK; Azadbakht L
    Public Health Nutr; 2012 May; 15(5):868-75. PubMed ID: 22008550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can low-carbohydrate diets be recommended for reducing cardiovascular risk?
    Berger A; Thorn E
    Curr Opin Endocrinol Diabetes Obes; 2022 Oct; 29(5):413-419. PubMed ID: 35869740
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dietary Modulations in Preventing Cardiometabolic Risk in Individuals with Type 2 Diabetes.
    Dal N; Bilici S
    Curr Nutr Rep; 2024 May; ():. PubMed ID: 38767826
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Mediterranean diet and dietary approach to stop hypertension (DASH)-style diet are differently associated with lipid profile in a large sample of Iranian adults: a cross-sectional study of Shahedieh cohort.
    Panbehkar-Jouybari M; Mollahosseini M; Salehi-Abargouei A; Fallahzadeh H; Mirzaei M; Hosseinzadeh M
    BMC Endocr Disord; 2021 Sep; 21(1):192. PubMed ID: 34548048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mediterranean Diet for Cardiovascular Risk Reduction in Chronic Kidney Disease.
    Bakis H; Chauveau P; Combe C; Pfirmann P
    Adv Kidney Dis Health; 2023 Nov; 30(6):496-501. PubMed ID: 38453265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-diet interventions and cardiovascular risk factors in postmenopausal women: A systematic review of controlled clinical trials.
    Amiri M; Karabegović I; van Westing AC; Verkaar AJCF; Beigrezaei S; Lara M; Bramer WM; Voortman T
    Maturitas; 2022 Jan; 155():40-53. PubMed ID: 34876248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet).
    Sofi F; Dinu M; Pagliai G; Cesari F; Gori AM; Sereni A; Becatti M; Fiorillo C; Marcucci R; Casini A
    Circulation; 2018 Mar; 137(11):1103-1113. PubMed ID: 29483085
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
    Diab A; Dastmalchi LN; Gulati M; Michos ED
    Vasc Health Risk Manag; 2023; 19():237-253. PubMed ID: 37113563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mediterranean diet for type 2 diabetes: cardiometabolic benefits.
    Esposito K; Maiorino MI; Bellastella G; Panagiotakos DB; Giugliano D
    Endocrine; 2017 Apr; 56(1):27-32. PubMed ID: 27395419
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omega 6 fatty acids for the primary prevention of cardiovascular disease.
    Al-Khudairy L; Hartley L; Clar C; Flowers N; Hooper L; Rees K
    Cochrane Database Syst Rev; 2015 Nov; (11):CD011094. PubMed ID: 26571451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease.
    Rees K; Hartley L; Flowers N; Clarke A; Hooper L; Thorogood M; Stranges S
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009825. PubMed ID: 23939686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein B and non-high-density lipoprotein cholesterol reveal a high atherogenicity in individuals with type 2 diabetes and controlled low-density lipoprotein-cholesterol.
    Fonseca L; Paredes S; Ramos H; Oliveira JC; Palma I
    Lipids Health Dis; 2020 Jun; 19(1):127. PubMed ID: 32505210
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pitavastatin in cardiometabolic disease: therapeutic profile.
    Masana L
    Cardiovasc Diabetol; 2013; 12 Suppl 1(Suppl 1):S2. PubMed ID: 23819752
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial.
    Mora S; Caulfield MP; Wohlgemuth J; Chen Z; Superko HR; Rowland CM; Glynn RJ; Ridker PM; Krauss RM
    Circulation; 2015 Dec; 132(23):2220-9. PubMed ID: 26408274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia?
    Agouridis AP; Rizos CV; Elisaf MS; Filippatos TD
    Rev Diabet Stud; 2013; 10(2-3):171-90. PubMed ID: 24380091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.